Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 11, 2006, Pages 784-792

  Seeger, John D ^a,b   West, William A ^a   Fife, Daniel ^c   Noel, Gary J ^c,d   Johnson, Larry N ^c   Walker, Alexander M ^a,b  

^a i3 Drug Safety   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Achilles tendon rupture; Case control; Epidemiology; fluoroquinolones

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACHILLES TENDON RUPTURE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL INFECTION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPARATHYROIDISM; INFANT; INJURY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD REVIEW; OBESITY; PHARMACOEPIDEMIOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SKIN INFECTION; SOFT TISSUE INFECTION; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; UROGENITAL TRACT INFECTION; VALIDATION PROCESS;

ACHILLES TENDON; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; FLUOROQUINOLONES; HUMANS; LOGISTIC MODELS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RISK FACTORS; RUPTURE; SEX DISTRIBUTION; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; TENDON INJURIES; UNITED STATES;

EID: 33749429683     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1214     Document Type: Article

References (36)

1. Leppilahti J, Puranen J, Orava S. Incidence of Achilles tendon rupture. Acta Orthop Scand 1996; 67: 277-279.
2. Maffulli N. Rupture of the Achilles tendon. J Bone Joint Surg Br 1999; 81-A(7): 1019-1036.
3. Leppilahti J, Orava S. Total Achilles tendon rupture: a review. Sports Med 1998; 25: 79-100.
4. Waterston SW, Maffulli N, Ewen SWB. Subcutaneous rupture of the Achilles tendon: basic science and some aspects of clinical practice. Br J Sports Med 1997; 31: 285-298.
5. Cetti R, Junge J, Vyberg M. Spontaneous rupture of the Achilles tendon is preceded by widespread and bilateral tendon damage and ipsilateral inflammation. Acta Orthop Scand 2003; 74: 78-84.
6. Gravlee JR, Hatch RL, Galea AM. Achilles tendon rupture: a challenging diagnosis. J Am Board Fam Pract 2000; 13: 371-373.
7. Rask MR. Achilles tendon rupture owing to rheumatoid disease: case report with a nine-year follow-up. JAMA 1978; 239: 435-436.
8. Dickey W, et al. Bilateral Achilles tendon rupture simulating peripheral neuropathy: unusual complication of steroid therapy. J Roy Soc Med 1987; 80: 386-387.
9. Hersh BL, Heath NS. Achilles tendon rupture as a result of oral steroid therapy. J Am Podiatr Med Assoc 2002; 92: 355-358.
10. Newnham DM, et al. Achilles tendon rupture: an underrated complication of corticosteroid treatment. Thorax 1991; 46: 853-854.
11. Ford LT, et al. Tendon rupture after local steroid injection. South Med J 1979; 72: 827-830.
12. Kleinman M, et al. Achilles tendon rupture following steroid injection. J Bone and Joint Surg 1983; 65: 1345-1347.
13. Khatiq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003; 36: 1404-1410.
14. Casparian JM, Luchi M, Moffat RE, Hinthorn D. Quinolones and tendon ruptures. South Med J 2000; 93: 488-491.
15. Harrell RM. Fluoroquinolone-induced tendinopathy: what do we know? South Med J 1999; 92: 622-625.
16. Movin T, et al. Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int 1997; 18: 297-299.
17. McGarvey WC, et al. Partial Achilles tendon ruptures associated with fluoroquinolone antibiotics: a case report and literature review. Foot Ankle Int 1996; 17: 496-498.
18. Royer RJ, Pierfitte C, Netter P. Features of tendon disorders with fluoroquinolones. Therapie 1994; 49: 75-76.
19. Szarfman A, Chen M, Blum MD. More on fluoroquinolone antibiotics and tendon rupture. N Engl J Med 1995; 332: 193.
20. Shakibael M, Pfister K, Schwabe R, Vorman J, Stahlman R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother 2000; 44: 261-266.
21. Simonin M-A, Gegout-Pottie P, Minn A, Gillet P, Netter P, Terlain B. Pefloxacin-induced Achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother 2000; 44: 867-872.
22. Van der Linden PD, Puijenbroek EPV, Feenstra J, Tveld BAI, Sturkenboom MCJM, Herings RMC, et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthrit Care Res 2001; 45: 235-239.
23. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin, and cifixime examined by observational cohort studies. Br J Clin Pharmacol 1996; 41: 277-284.
24. Pierfitte C, Royer RJ. Tendon disorders with fluoroquinolones. Therapie 1996; 51: 419-420.
25. Royer RJ. Adverse drug reactions with fluoroquinolones. Therapie 1996; 51: 414-416.
26. Van der Linden PD, de Lei J, Nab HW, Knot A, Stricker BH. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 1999; 48: 433-437.
27. Van der Linden PD, Sturkenboom MCJM, Herings RMC, Leufkens HGM, Stricker BHC. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. Br Med J 2002; 324: 1306-1307.
28. Mathis AS, Chan V, Gryszkiesicz M, Adamson RT, Friedman GS. Levofloxacin-associated Achilles tendon rupture. Ann Pharmacother 2003; 37: 1014-1017.
29. Vanek D, Saxena A, Boggs JM. Fluoroquinolone therapy and Achilles tendon rupture. J Am Podiatr Med Assoc 2003; 93: 333-335.
30. Melhus A, Apelqvist J, Larsson J, Eneroth M. Levofloxacin-associated Achilles tendon rupture and tendinopathy. Scand J Infect Dis 2003; 35: 768-770.
31. Van der Linden PD, Sturkenboom MCJM, Herings RMC, Leufkens HGM, Rowlands S, Stricker BHC. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003; 163: 1801-1807.
32. Van der Linden PD, Nab HW, Simonian S, Stricker BHC, Leufkens HGM, Herings RMC. Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands. Pharm World Sci 2001; 23: 89-93.
33. Quam L, Ellis LBM, Venus P, Clouse J, Taylor CG, Leatherman S. Using claims data for epidemiologic research: the concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Medical Care 1993; 31: 498-507.
34. Lanza LL, Dreyer NA, Schultz NJ, Walker AM. Use of insurance claims in epidemiologic research: identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis and renal disease. PD Safe 1995; 4: 239-248.
35. Breiman L, Freidman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Wadsworth: Belmont, CA, 1983.
36. Drug Facts and Comparisons. Facts and Comparisons. St. Louis. 2000.